Target intelligence / Profile preview

RERG intronic transcript 1 (RERG-IT1)

Target
RERG-IT1
Molecular classification
Other, Long non-coding RNA, lncRNA
01

Overview

RERG intronic transcript 1 (RERG-IT1) is annotated as a long non-coding RNA (lncRNA) associated with the RERG gene locus, which encodes a RAS-family GTPase known as RAS like estrogen regulated growth inhibitor[1][4]. This transcript is non-protein-coding and there is no evidence in major genomic or pharmacological databases that it encodes a therapeutic target, functions as a receptor, enzyme, transporter, or other canonical target class. There are also no known biological mechanisms, disease associations, biomarker uses, or drugs acting on this transcript according to current scientific resources[1][4][5]. The limited information suggests that RERG-IT1 is either a newly annotated or weakly characterized non-coding RNA, and it is not established as a target of therapeutic interest at this time. Note: If you are seeking information on the canonical RERG protein, there are significantly more data available on its tumor suppressor role as a protein-coding gene. For RERG-IT1, there is no evidence supporting therapeutic targeting, functional relevance, or disease association in current references[1][4][5].

Other names
RERG-IT1RERG intronic transcript 1 (non-protein coding)RERG-AS1 (sometimes, though RERG-AS1 is a separate annotated lncRNA)

Beyond the preview

Go deeper on RERG intronic transcript 1 (RERG-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RERG intronic transcript 1 (RERG-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call